|
| | (3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one Basic information |
| | (3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one Chemical Properties |
| Boiling point | 651.4±55.0 °C(Predicted) | | density | 1.297±0.06 g/cm3(Predicted) | | solubility | Chloroform, Dichloromethane, Ethyl Acetate, Methol, | | pka | 2.19±0.61(Predicted) | | form | Foam | | color | Pale Yellow |
| | (3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one Usage And Synthesis |
| Chemical Properties | Pale Yellow Foam | | Uses | An impurity formed during the preparation of Montelukast. |
| | (3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one Preparation Products And Raw materials |
|